Study of NTB-928 in R/R OC

Clinical trial NCT07690189 · RECRUITING

Trial details

NCT number: NCT07690189
Sponsor: TeneoSeven, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Ovarian Carcinoma

Start date: 2026-06-29
Primary completion: 2028-06-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.